Anne Moxhon

428 total citations
8 papers, 325 citations indexed

About

Anne Moxhon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anne Moxhon has authored 8 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anne Moxhon's work include Prostate Cancer Treatment and Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Anne Moxhon is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Anne Moxhon collaborates with scholars based in Belgium, France and United States. Anne Moxhon's co-authors include Emmanuelle Bompas, Sandra Schmitz, Stéphanie Henry, F.X. Wese, Paul J. Van Cangh, Reinier Opsomer, Francis Lorge, Jean‐Pascal Machiels, Sylvie Zanetta and Françoise Richard and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Anne Moxhon

8 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Moxhon Belgium	6	186	134	102	76	49	8	325
Petra Stegmaier Germany	6	116 0.6×	68 0.5×	124 1.2×	18 0.2×	25 0.5×	10	257
I. Toledano France	6	143 0.8×	77 0.6×	87 0.9×	127 1.7×	95 1.9×	16	287
Laura Faivre France	9	158 0.8×	181 1.4×	63 0.6×	31 0.4×	57 1.2×	16	307
Antonio Stefanelli Italy	9	130 0.7×	102 0.8×	22 0.2×	20 0.3×	46 0.9×	38	287
To Wai Leung China	9	182 1.0×	188 1.4×	53 0.5×	357 4.7×	260 5.3×	13	494
O. Nascimben Italy	11	60 0.3×	173 1.3×	118 1.2×	28 0.4×	67 1.4×	21	352
Gabriel Calzada United States	9	59 0.3×	144 1.1×	50 0.5×	207 2.7×	210 4.3×	13	402
Dominique Rosine France	7	154 0.8×	149 1.1×	72 0.7×	146 1.9×	59 1.2×	9	311
Croix C. Fossum United States	8	82 0.4×	262 2.0×	172 1.7×	23 0.3×	61 1.2×	14	414

Countries citing papers authored by Anne Moxhon

Since Specialization

Citations

This map shows the geographic impact of Anne Moxhon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Moxhon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Moxhon more than expected).

Fields of papers citing papers by Anne Moxhon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Moxhon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Moxhon. The network helps show where Anne Moxhon may publish in the future.

Co-authorship network of co-authors of Anne Moxhon

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Moxhon. A scholar is included among the top collaborators of Anne Moxhon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Moxhon. Anne Moxhon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Carrasco, Javier, Jean-Charles Coche, Christine Sempoux, et al.. (2014). Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer. Targeted Oncology. 10(3). 375–383. 15 indexed citations

Médioni, Jacques, Joseph Kerger, Lionel D’Hondt, et al.. (2012). Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 70(2). 293–303. 6 indexed citations

Schmitz, Sandra, Stéphanie Henry, L. Geoffrois, et al.. (2012). Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). Annals of Oncology. 23(8). 2153–2161. 62 indexed citations

Schmitz, Sandra, Stéphanie Henry, Sylvie Zanetta, et al.. (2010). Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: GORTEC 2008-02.. Journal of Clinical Oncology. 28(15_suppl). 5500–5500. 12 indexed citations

Machiels, Jean‐Pascal, Stéphanie Henry, Sylvie Zanetta, et al.. (2009). Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01. Journal of Clinical Oncology. 28(1). 21–28. 129 indexed citations

Medioni, J., Joseph Kerger, J.-L. Canon, et al.. (2009). A phase I study of sorafenib in association with docetaxel-prednisone in chemonaive metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 27(15_suppl). 5153–5153. 1 indexed citations

Moxhon, Anne, et al.. (2000). À propos du pad-test : il mesure le niveau de continence d'un patient dans une situation fonctionnelle OUI MAIS !. DIAL (Catholic University of Leuven). 27(4). 146–148. 1 indexed citations

Cangh, Paul J. Van, Françoise Richard, Francis Lorge, et al.. (1998). ADJUVANT RADIATION THERAPY DOES NOT CAUSE URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMIZED STUDY. The Journal of Urology. 159(1). 164–166. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact